JP2021534084A5 - - Google Patents

Info

Publication number
JP2021534084A5
JP2021534084A5 JP2021505646A JP2021505646A JP2021534084A5 JP 2021534084 A5 JP2021534084 A5 JP 2021534084A5 JP 2021505646 A JP2021505646 A JP 2021505646A JP 2021505646 A JP2021505646 A JP 2021505646A JP 2021534084 A5 JP2021534084 A5 JP 2021534084A5
Authority
JP
Japan
Prior art keywords
optionally substituted
optionally
substituted
alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021505646A
Other languages
English (en)
Japanese (ja)
Other versions
JP7904004B2 (ja
JP2021534084A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/045259 external-priority patent/WO2020033377A1/en
Publication of JP2021534084A publication Critical patent/JP2021534084A/ja
Publication of JP2021534084A5 publication Critical patent/JP2021534084A5/ja
Application granted granted Critical
Publication of JP7904004B2 publication Critical patent/JP7904004B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021505646A 2018-08-06 2019-08-06 ヒストンデメチラーゼ5阻害剤およびその使用 Active JP7904004B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862715122P 2018-08-06 2018-08-06
US62/715,122 2018-08-06
US201862715687P 2018-08-07 2018-08-07
US62/715,687 2018-08-07
US201962803332P 2019-02-08 2019-02-08
US62/803,332 2019-02-08
PCT/US2019/045259 WO2020033377A1 (en) 2018-08-06 2019-08-06 Histone demethylase 5 inhibitors and uses thereof

Publications (3)

Publication Number Publication Date
JP2021534084A JP2021534084A (ja) 2021-12-09
JP2021534084A5 true JP2021534084A5 (enExample) 2022-08-15
JP7904004B2 JP7904004B2 (ja) 2026-08-12

Family

ID=69414411

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021505646A Active JP7904004B2 (ja) 2018-08-06 2019-08-06 ヒストンデメチラーゼ5阻害剤およびその使用

Country Status (6)

Country Link
US (1) US20230382865A1 (enExample)
EP (1) EP3833347A4 (enExample)
JP (1) JP7904004B2 (enExample)
AU (1) AU2019318046B2 (enExample)
CA (1) CA3106548A1 (enExample)
WO (1) WO2020033377A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11232861B1 (en) 2021-06-18 2022-01-25 Argos Health Inc. Systems and methods for displaying predetermined information for clinical use
WO2024233765A1 (en) * 2023-05-09 2024-11-14 Ohio State Innovation Foundation Therapeutic approach to block terminal exhaustion of t cells and synergize the efficacy of t cell immunotherapies

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9408577D0 (en) * 1994-04-29 1994-06-22 Fujisawa Pharmaceutical Co New compound
WO2005046683A1 (en) * 2003-10-07 2005-05-26 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
CN103717757A (zh) * 2011-05-24 2014-04-09 威斯特研究所 用于调节爱泼斯坦-巴尔核抗原1的活性的组合物和方法
ES2654143T3 (es) 2012-10-02 2018-02-12 Gilead Sciences, Inc. Inhibidores de desmetilasas de histonas
SG10201707027SA (en) * 2013-02-27 2017-09-28 Epitherapeutics Aps Inhibitors of histone demethylases
US9919998B2 (en) * 2014-02-06 2018-03-20 Rutgers, The State University Of New Jersey Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides
JP2017512804A (ja) * 2014-03-31 2017-05-25 ギリアード サイエンシーズ, インコーポレイテッド ヒストン脱メチル化酵素の阻害剤
JP2017526675A (ja) 2014-08-27 2017-09-14 ギリアード サイエンシーズ, インコーポレイテッド ヒストンデメチラーゼを阻害するための化合物および方法
CN105837575B (zh) * 2015-01-13 2019-01-15 四川大学 3-乙炔基吡唑并嘧啶衍生物及其制备方法和用途
WO2024053491A1 (ja) 2022-09-06 2024-03-14 ソニーグループ株式会社 情報処理装置、情報処理方法、および、コンピュータ読み取り可能な非一時的記憶媒体

Similar Documents

Publication Publication Date Title
JP2023508982A5 (enExample)
JP2022529700A5 (enExample)
JP2023530231A5 (enExample)
JP2019527682A5 (enExample)
IL268030B2 (en) Bicyclics as allosteric shp2 inhibitors
JP2020509022A5 (enExample)
JP2022544714A5 (enExample)
JP2017502006A5 (enExample)
JP2017537940A5 (enExample)
JP2019524883A5 (enExample)
JP2019094345A5 (enExample)
JP2020517616A5 (enExample)
JP2019518766A5 (enExample)
JP2016510323A5 (enExample)
JP2019529444A5 (enExample)
JP2010539095A5 (enExample)
JP2020535165A5 (enExample)
JP2017504595A5 (enExample)
JP2018522866A5 (enExample)
JP2022548250A5 (enExample)
JP2014520108A5 (enExample)
JP2015504076A5 (enExample)
JP2013502441A5 (enExample)
WO2019012172A1 (es) Nuevos derivados heteroaryl amida como inhibidores selectivos de histona deacetilasa 1 y 2 (hdac1/2)
JP2010524899A5 (enExample)